Shore Capital Partnershas closed a $112.5 million health care-focused private equity fund. Shore Capital Partners is the latest private equity firm to benefit from the most robust fundraising climate in years, and many have recently closed funds. 

The fund, Shore Capital Partners Fund I, was oversubscribed, and will continue the investment strategy of Shore's previous investment vehicles – focusing on control buyouts of microcap health care businesses. Targets will have between $1 million and $5 million in Ebitda, and Shore will invest between $10 million and $15 million per platform.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.